Es gab 50 kürzliche Insider-Transaktionen für Aeglea BioTherapeutics, Inc. (AGLE), darunter 35 Käufe und 8 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $29.2M und die gesamten Insider-Verkäufe auf $1.5M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Fairmount Funds Management Llc, Burrows Scott L, Turtle Cameron. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — AGLE
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2023-12-29 |
Fairmount Funds Management Llc |
10 Percent Owner |
Sonstige (Verkauf) |
3,435,480 |
- |
- |
- |
| 2023-12-22 |
Burrows Scott L |
Chief Financial Officer |
RSU-Zuteilung |
134,953 |
- |
- |
134,953 |
| 2023-12-07 |
Fairmount Funds Management Llc |
10 Percent Owner |
RSU-Zuteilung |
16,667 |
- |
- |
16,667 |
| 2023-11-24 |
Turtle Cameron |
Chief Executive Officer |
Umwandlung (Verkauf) |
18,086 |
- |
- |
- |
| 2023-11-24 |
Fairmount Funds Management Llc |
10 Percent Owner |
Umwandlung (Verkauf) |
85,887 |
- |
- |
- |
| 2023-11-24 |
Albers Jeffrey W. |
Director |
Umwandlung (Verkauf) |
859 |
- |
- |
- |
| 2023-11-22 |
Albers Jeffrey W. |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2023-11-22 |
Albers Jeffrey W. |
Director |
RSU-Zuteilung |
50,000 |
$10.39 |
$519.5K |
50,000 |
| 2023-11-22 |
Stelzer Laurie |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2023-11-22 |
Stelzer Laurie |
Director |
RSU-Zuteilung |
50,000 |
$10.39 |
$519.5K |
50,000 |
| 2023-11-22 |
Turtle Cameron |
Chief Executive Officer |
RSU-Zuteilung |
374,000 |
$10.39 |
$3.89M |
374,000 |
| 2023-11-22 |
Albers Jeffrey W. |
Director |
Unbekannt |
34,360 |
- |
- |
- |
| 2023-11-22 |
Albers Jeffrey W. |
Director |
RSU-Zuteilung |
50,000 |
$10.39 |
$519.5K |
50,000 |
| 2023-09-01 |
King-jones Heidy |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2023-09-01 |
King-jones Heidy |
See Remarks |
RSU-Zuteilung |
13,495,255 |
$0.58 |
$7.83M |
13,495,255 |
| 2023-09-01 |
Burrows Scott L |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2023-09-01 |
Burrows Scott L |
Chief Financial Officer |
RSU-Zuteilung |
10,121,441 |
$0.58 |
$5.87M |
10,121,441 |
| 2023-06-22 |
Magovcevic-liebisch Ivana |
Director |
RSU-Zuteilung |
1,950,000 |
$0.30 |
$585K |
1,950,000 |
| 2023-06-22 |
Cox Russell J. |
Director |
RSU-Zuteilung |
1,950,000 |
$0.30 |
$585K |
1,950,000 |
| 2023-06-22 |
Lawton Alison Frances |
Director |
RSU-Zuteilung |
1,950,000 |
$0.30 |
$585K |
1,950,000 |
| 2023-06-22 |
Smith Hunter C |
Director |
RSU-Zuteilung |
1,950,000 |
$0.30 |
$585K |
1,950,000 |
| 2023-06-22 |
Turtle Cameron |
Chief Operating Officer |
Veräußerung |
18,086,000 |
- |
- |
- |
| 2023-06-22 |
Henderson Michael Thomas |
Director |
Veräußerung |
1,950,000 |
$0.30 |
$585K |
- |
| 2023-06-22 |
Fairmount Funds Management Llc |
10 Percent Owner |
Unbekannt |
1,950,000 |
$0.30 |
$585K |
- |
| 2023-06-22 |
Alspaugh Jonathan |
President and CFO |
RSU-Zuteilung |
19,787,969 |
$0.30 |
$5.94M |
19,787,969 |
| 2023-02-23 |
Hanley Jr. Michael Conick |
Chief Business Officer |
RSU-Zuteilung |
500,000 |
$0.44 |
$220K |
500,000 |
| 2023-02-23 |
Kastenmayer James Paul |
General Counsel |
RSU-Zuteilung |
500,000 |
$0.44 |
$220K |
500,000 |
| 2023-02-23 |
Alspaugh Jonathan |
Chief Financial Officer |
RSU-Zuteilung |
640,000 |
$0.44 |
$281.6K |
640,000 |
| 2023-02-23 |
Neuman Linda L |
Chief Medical Officer |
RSU-Zuteilung |
550,000 |
$0.44 |
$242K |
550,000 |
| 2022-11-29 |
Goldberg Jeff Marc |
President and CEO |
Unbekannt |
- |
- |
- |
- |
| 2022-11-29 |
Goldberg Jeff Marc |
President and CEO |
RSU-Zuteilung |
1,884,838 |
- |
- |
1,884,838 |
| 2022-11-14 |
Neuman Linda L |
Chief Medical Officer |
Veräußerung |
- |
- |
- |
4,000 |
| 2022-11-14 |
Neuman Linda L |
Chief Medical Officer |
RSU-Zuteilung |
25,000 |
- |
- |
25,000 |
| 2022-08-25 |
Souza Marcio |
Director |
Informierter Kauf |
90,000 |
$0.56 |
$50.47K |
90,000 |
| 2022-08-23 |
Sloan Leslie |
Chief Operating Officer |
RSU-Zuteilung |
130,000 |
$0.68 |
$88.4K |
130,000 |
| 2022-08-23 |
Hanley Jr. Michael Conick |
Chief Business Officer |
RSU-Zuteilung |
130,000 |
$0.68 |
$88.4K |
130,000 |
| 2022-08-23 |
Kastenmayer James Paul |
Interim CEO & General Counsel |
Veräußerung |
130,000 |
$7.03 |
$913.9K |
- |
| 2022-08-23 |
Kastenmayer James Paul |
Interim CEO & General Counsel |
RSU-Zuteilung |
130,000 |
$0.68 |
$88.4K |
130,000 |
| 2022-08-23 |
Alspaugh Jonathan |
Chief Financial Officer |
RSU-Zuteilung |
130,000 |
- |
- |
130,000 |
| 2022-06-08 |
Hanley Jr. Michael Conick |
Chief Commercial Officer |
Informierter Kauf |
28,200 |
$0.71 |
$20.02K |
36,200 |
| 2022-06-07 |
Lawlis V Bryan |
Director |
RSU-Zuteilung |
43,000 |
$0.73 |
$31.39K |
43,000 |
| 2022-06-07 |
Magovcevic-liebisch Ivana |
Director |
RSU-Zuteilung |
43,000 |
$0.73 |
$31.39K |
43,000 |
| 2022-06-07 |
Mahatme Sandesh |
Director |
RSU-Zuteilung |
43,000 |
$0.73 |
$31.39K |
43,000 |
| 2022-06-07 |
Cox Russell J. |
Director |
RSU-Zuteilung |
43,000 |
$0.73 |
$31.39K |
43,000 |
| 2022-06-07 |
Smith Hunter C |
Director |
RSU-Zuteilung |
43,000 |
$0.73 |
$31.39K |
43,000 |
| 2022-06-07 |
Shanafelt Armen |
Director |
RSU-Zuteilung |
43,000 |
$0.73 |
$31.39K |
43,000 |
| 2022-06-07 |
Souza Marcio |
Director |
RSU-Zuteilung |
43,000 |
- |
- |
43,000 |
| 2022-06-07 |
Lawton Alison Frances |
Director |
RSU-Zuteilung |
43,000 |
$0.73 |
$31.39K |
43,000 |
| 2022-03-16 |
Quinn Anthony G. |
President & CEO |
Informierter Kauf |
80,079 |
$2.34 |
$187.71K |
550,540 |
| 2022-03-15 |
Quinn Anthony G. |
President & CEO |
Informierter Kauf |
42,417 |
$1.86 |
$78.94K |
473,461 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
